Why Investors Are Watching Nutrition More Closely Than Ever
Health, Value and the Future of the Food Industry
In recent years, few voices in European sustainable finance have been as consistently clear on the intersection between long-term value creation and societal outcomes as Catherine Howarth. As chief executive of ShareAction and a member of the RAOEurope global advisory board, she has long argued that financial markets perform best when companies confront systemic risks early rather than react to them belatedly.
The global food industry now sits squarely within that debate. The strategic decisions of companies such as Nestlé, Unilever, Danone and others are no longer judged solely on their ability to drive sales growth or protect margins. Investors increasingly ask a more fundamental question: are these companies positioned to succeed in a world where consumer health, regulation and societal expectations are evolving rapidly?
Recent discussion of Nestlé’s strategic overhaul has brought this issue sharply into focus. The company’s restructuring plan raises a critical question for investors and policymakers alike: will consumer health sit at the centre of value creation, or remain one of several competing priorities?
For long-term investors, the answer matters enormously.
The Rising Economic Cost of Poor Nutrition
The scale of the challenge facing the global food system is difficult to overstate. According to estimates from the World Obesity Federation, the economic burden of obesity could approach $4tn annually by 2035 if current trends continue. The implications extend far beyond healthcare systems. Rising rates of diet-related disease affect productivity, insurance costs, public spending and ultimately economic growth.
For companies operating in the food sector, these trends translate into a complex mix of opportunity and risk. Demand for healthier products is rising across many markets, particularly in Europe and North America. At the same time, regulatory scrutiny is increasing, with governments exploring measures ranging from sugar taxes to stricter marketing rules.
Litigation risk is also beginning to enter the conversation, echoing earlier developments in the tobacco and pharmaceutical industries. And reputational considerations—particularly among younger consumers—are increasingly influential in shaping purchasing behaviour.
From an investor perspective, these developments represent a structural shift rather than a cyclical trend. Companies that successfully reposition their portfolios toward healthier products may unlock new growth markets. Those that fail to adapt risk losing relevance in an evolving consumer landscape.
Nestlé: A Strategic Inflection Point
Against this backdrop, Nestlé’s strategic review has attracted significant attention. As the world’s largest food manufacturer, the company occupies a unique position within the global food ecosystem. Its portfolio spans categories ranging from confectionery and beverages to nutrition products and pet care.
However, Nestlé remains materially exposed to the health debate. By its own assessment, only around one-third of its sales currently meet recognised standards for healthier products. While the company has taken steps in recent years to reformulate products and expand its nutrition-focused divisions, progress has been uneven.
Investors therefore view Nestlé’s current strategic overhaul as a potential turning point. The reorganisation offers an opportunity to clarify how the company intends to align its product portfolio with changing consumer expectations.
For a company of Nestlé’s scale, nutrition is not simply a marketing issue—it is a strategic test. A credible commitment to improving the health profile of its products, supported by measurable targets and executive accountability, would send a powerful signal to the market.
Without such clarity, investors may question whether the company is moving quickly enough to capture emerging opportunities.
Why Investors Care About Nutrition
Historically, debates about food and health were often framed as ethical or public-policy concerns. Today they increasingly appear in financial analysis.
Institutional investors are particularly sensitive to long-term structural risks. Pension funds, sovereign wealth funds and insurance companies manage capital on time horizons measured in decades. They therefore look beyond quarterly earnings to assess how social and environmental trends may reshape industries.
In the case of food manufacturers, nutrition is now viewed through several interconnected lenses:
Consumer demand: Rising awareness of diet-related health issues is influencing purchasing patterns. Healthier alternatives are gaining market share across categories from snacks to beverages.
Regulatory pressure: Governments in Europe, Latin America and parts of Asia have introduced taxes, labelling requirements and advertising restrictions aimed at reducing consumption of high-sugar or high-salt products.
Legal risk: As evidence linking diet and disease becomes more widely accepted, food companies may face litigation similar to earlier waves affecting tobacco or pharmaceuticals.
Reputational impact: Companies perceived as contributing to public-health challenges risk losing trust among consumers and investors.
For investors focused on long-term value creation, these factors combine to form a compelling case for change.
The Wider Industry Landscape
While Nestlé occupies the spotlight, it is far from alone in confronting these challenges. The global food industry is undergoing a gradual but significant transformation as companies respond to shifting expectations around health and wellbeing.
Unilever
Unilever has been among the more proactive companies in linking nutrition and sustainability strategies. The company has committed to improving the nutritional quality of its products and has set targets for reducing salt, sugar and calories across key categories.
Unilever’s broader “Future Foods” initiative seeks to expand plant-based offerings while promoting more sustainable and nutritious diets. For investors, these initiatives represent an attempt to align growth with changing consumer preferences.
However, progress remains uneven, and critics argue that further transparency is needed regarding the health profile of the company’s portfolio.
Danone
Danone has positioned itself more explicitly around health and nutrition, particularly through its focus on dairy alternatives, specialised nutrition and probiotic products. The company’s strategy reflects a belief that nutrition-driven innovation can support long-term growth.
Danone’s emphasis on science-based nutrition and medical research has helped differentiate its portfolio. Yet the company also faces pressures to balance its health positioning with financial performance, particularly in competitive global markets.
PepsiCo and Coca-Cola
Although primarily known for beverages and snacks, companies such as PepsiCo and Coca-Cola have also begun to diversify into lower-sugar drinks, functional beverages and healthier snack options.
These companies face some of the most intense scrutiny due to the historic association of sugary drinks with rising obesity rates. Reformulation, portion control and the introduction of alternative product lines are now central elements of their strategies.
Mondelez and Other Snack Producers
Snack manufacturers face particular challenges because their core products often rely on ingredients linked to health concerns. Companies such as Mondelez have responded by experimenting with portion control, reformulation and the introduction of alternative ingredients.
While these efforts demonstrate progress, they also illustrate the complexity of balancing consumer demand, taste preferences and nutritional improvements.
The Strategic Opportunity
For food manufacturers willing to embrace change, the evolving health landscape also offers significant opportunities.
The global market for healthier food products—from plant-based alternatives to functional beverages—is expanding rapidly. Innovation in areas such as alternative proteins, personalised nutrition and food technology is creating new avenues for growth.
Companies that move decisively to reshape their portfolios may benefit from:
Access to new consumer segments
Improved brand trust
Reduced regulatory risk
Enhanced investor confidence
In this sense, the transition toward healthier products should not be viewed purely as a defensive response to public-health concerns. It is also a strategic growth opportunity.
Leadership and Accountability
One of the recurring themes in Catherine Howarth’s commentary on corporate governance is the importance of clear, time-bound commitments backed by executive accountability.
This principle applies directly to the food industry. Strategic statements about nutrition or sustainability carry little weight unless they are accompanied by measurable targets and transparent reporting.
Investors increasingly expect companies to disclose:
the proportion of sales derived from healthier products
progress toward reformulation targets
the integration of health metrics into executive remuneration.
These expectations reflect a broader shift in corporate governance, where long-term societal challenges are increasingly viewed as material business risks.
A Moment of Strategic Choice
The food industry now stands at an inflection point. The convergence of public-health concerns, regulatory change and evolving consumer preferences is reshaping the competitive landscape.
For companies such as Nestlé, the question is no longer whether nutrition will influence strategy, but how quickly and decisively they will respond.
The current strategic overhaul offers Nestlé a rare opportunity to articulate a clear vision for the future. A credible global commitment to improving the health profile of its products—supported by transparent reporting and leadership accountability—could demonstrate that the company intends to lead rather than follow.
For investors seeking resilient long-term positioning, such clarity would be welcome.
The Role of Investor Leadership
The growing attention to nutrition and health within financial markets reflects a broader transformation in investor expectations. Increasingly, capital is flowing toward companies that recognise the interconnected nature of economic performance and societal outcomes.
As Catherine Howarth has often argued, the most successful companies in the coming decades will be those that anticipate systemic challenges rather than react to them.
The global food industry’s response to the health agenda will therefore be closely watched—not only by consumers and policymakers, but by investors seeking evidence that companies are positioning themselves for a changing world.
In this context, the debate around Nestlé’s strategy represents more than a single corporate decision. It highlights a fundamental question about the future of food: will the industry lead the transition toward healthier diets, or simply adapt when pressure becomes unavoidable?
For financial leaders across Europe and beyond, the answer carries implications far beyond the supermarket shelf.
